Gilbert H. Kliman - 16 Jun 2022 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Director
Signature
/s/ Samuel Gesten as attorney-in-fact for Dr. Gilbert Kliman.
Issuer symbol
STAA
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 18:40:10 UTC
Previous filing
06 Jun 2022
Next filing
29 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $0 +355 +12% $0.000000 3,340 16 Jun 2022 Direct F1
transaction STAA Common Stock Options Exercise $0 +2,899 +87% $0.000000 6,239 16 Jun 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock.
F2 The restrictions on the 2899 restricted shares of common stock awarded on his re-election to the Board of Directors lapse on the earlier of June 16, 2023 or the Corporation's 2023 Annual Meeting, subject to his continued service through that date.

Remarks:

On June 16, 2022, STAAR Surgical Company granted Dr. Kliman, a non-employee director, 2899 restricted shares of the Corporation's common stock on his re-election to the Board of Directors.